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The implementation of highly active antiretroviral therapy 
(HAART) has meant that HIV is now commonly viewed as 
a chronic illness (Biswas, 2007; Vetter and Donnelly, 2006). 
Although this has resulted in significant improvements in 
the physical health of people living with HIV (PLWH), 
there continues to be a higher prevalence of anxiety and 
depression in this population (Bing et al., 2001; Grierson 
et al., 2009; Nacher et al., 2010). Comorbidity between 
anxiety and depressive symptoms in PLWH is also high 
(Pence et al., 2006; Schumacher et al., 2012). Furthermore, 
increased psychological distress in PLWH has also been 
shown to negatively affect HIV disease progression 
(Leserman, 2008; Schuster et al., 2012). Thus, it is vital to 
understand the potential variables and processes influenc-
ing depression and anxiety symptoms in PLWH.
HIV stigma continues to be a major stressor for PLWH 
and has consistently been associated with more psychologi-
cal distress (Earnshaw and Chaudoir, 2009; Hatzenbuehler 
et al., 2011; Logie and Gadalla, 2009). Stigma towards 
PLWH may be connected to HIV as a condition, which is 
seen as preventable, incurable, contagious and potentially 
appearance altering (Herek, 1999). Similarly, HIV stigma 
towards gay, bisexual and other men who have sex with 
men (MSM) may also be connected to prejudice around 
same sex behaviour, leading to stigma layering, with MSM 
stigmatised as a result of their HIV diagnosis and sexual 
orientation (Fay et al., 2011; Herek and Capitanio, 1999; 
Pickles et al., 2009; Reidpath and Chan, 2005).
HIV stigma is thought to occur through at least three 
processes (Earnshaw and Chaudoir, 2009): (a) Enacted 
Stigma (also called Experienced Stigma) refers to percep-
tions of overt or actual HIV stigma (Phillips et al., 2011; 
Scambler and Paoli, 2008), (b) Anticipated Stigma (also 
called Felt or Perceived Stigma) is the expectation of nega-
tive societal attitudes and discrimination from others 
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(Earnshaw and Chaudoir, 2009; Herek et al., 2013; Phillips 
et al., 2011) and (c) Internalised Stigma (also called Self-
Stigma) is the incorporation of these negative prejudicial 
attitudes into one’s self-concept (Corrigan and Watson, 
2002; Phillips et al., 2011). In a review by Earnshaw and 
Chaudoir (2009), greater enacted, internalised and antici-
pated HIV stigma perceptions of PLWH were consistently 
associated with poor mental health and low social support.
Given the high levels of depression and anxiety symp-
toms and continued perceptions of HIV stigma in MSM, 
there is a need to better understand the psychological pro-
cesses linking HIV stigma to mental health outcomes. This 
study will examine the role of metacognitions in explaining 
differences in depression and anxiety symptoms in response 
to perceptions of HIV stigma in MSM living with HIV. 
Metacognition refers to the stored knowledge and experi-
ences of thought processes and the strategies likely to reach 
one’s objective, and involves beliefs and appraisals of one’s 
cognitions (Flavell, 1979). One model of metacognition 
that has shown to be helpful in explaining psychopathology 
is the metacognitive model developed by Adrian Wells 
(1995). In this model, Wells (2008) proposed that depres-
sion and anxiety result from an unhelpful internal state 
called the cognitive attentional syndrome (CAS), which 
consists of perseverative thinking such as worry or rumina-
tion, threat monitoring and ineffective cognitive coping 
strategies. For example, someone experiencing high levels 
of social anxiety may have a CAS that involves a perse-
verative thinking style of worry that others will reject her or 
him, an attentional bias towards threat cues such as facial 
expressions of others or unhelpful cognitive coping strate-
gies such as thought suppression. The experience of worry, 
attentional bias to threat cues and the use of ineffective 
coping strategies manifest themselves in the symptoms 
associated with the social anxiety. The CAS is thought to 
be triggered and maintained by metacognitive beliefs 
(i.e. unhelpful beliefs and appraisals of one’s cognitions) 
(Wells, 2008). The meta-beliefs can be classified as positive 
meta-beliefs (such as ‘If I worry about all possibilities I can 
avoid failure’), which provide the motivation to engage in 
perseverative thinking, and negative meta-beliefs (e.g. 
‘Worrying is uncontrollable’), which provide the motivation 
to employ a coping strategy to manage the perseverative 
thinking (Wells, 2008). An attentional bias towards threat 
cues and ineffective coping strategies are then linked to the 
maintenance of psychological disorders (Wells and Carter, 
2009; Wells and Davies, 1994). While Well’s metacognitive 
model was initially developed to explain the pathology of 
anxiety and depression, more recent developments have 
shown the application of the model to other forms of psy-
chopathology such as alcohol misuse (Spada et al., 2013) 
and eating disorders (Vann et al., 2013).
This study will use Wells and Cartwright-Hatton’s (2004) 
30-item Metacognitions Questionnaire (MCQ-30) to assess 
five different types of metacognitive beliefs. Negative 
Metacognitive Beliefs represents beliefs that worry is 
dangerous and uncontrollable and has consistently been iden-
tified as the strongest metacognitive predictor of psychologi-
cal distress, showing significant positive relationships with 
depression and anxiety symptoms (Allot et al., 2005; Spada 
et al., 2008a, 2008b; Tajrishi et al., 2011; Yılmaz et al., 2011). 
Another metacognitive belief termed Need to Control 
Thoughts represents beliefs that one should be in continuous 
control of one’s thoughts (Wells and Cartwright-Hatton, 
2004) and has shown significant positive associations with 
both depression and anxiety symptoms in non-clinical sam-
ples (Spada et al., 2008b; Yılmaz et al., 2011).The metacogni-
tive belief entitled Cognitive Confidence is focused on a lack 
of confidence in cognitive processes such as memory (Wells 
and Cartwright-Hatton, 2004) and is associated with depres-
sive rather than anxious symptoms (Spada et al., 2008a). 
Positive Metacognitive Beliefs refers to the perceived benefits 
of worry to prevent distress and improve mood while 
Cognitive Self-Consciousness involves the tendency to moni-
tor thoughts. Neither appear to be associated with depressive 
or anxious symptoms (Spada et al., 2008a).
Metacognitive beliefs dictating the meaning and impor-
tance placed on one’s cognitions are believed to trigger the 
use of ineffective thought control strategies aimed at sup-
pressing or removing distressing thoughts (Wells and 
Carter, 2009). Research assessing these strategies has typi-
cally used Wells and Davies (1994) Thought Control 
Questionnaire (TCQ) that examines five thought control 
strategies. Worry as a thought control strategy involves 
using minor worries as a means of suppressing more upset-
ting thoughts and has been associated with both anxiety 
(generalized anxiety disorder (GAD); Coles and Heimberg, 
2005; Wells and Carter, 2009) and depression (Barahmand, 
2009; Wells and Carter, 2009). Punishment as a thought 
control strategy involves using behaviours such as slap-
ping, pinching and yelling at oneself to manage distressing 
thoughts (Wells and Davies, 1994) and may be more 
strongly linked to generalised anxiety than to depressive 
symptoms (Wells and Davies, 2009). In contrast, thought 
control strategies focused on talking about distressing 
thoughts with peers (Social), rationally analysing thoughts 
(Reappraisal) and focusing on work or more pleasant activ-
ities (Distraction) have shown either non-significant or 
negative associations with psychological distress (Wells, 
2008). This study builds upon a recent study which further 
demonstrates the important role of both metacognitions and 
thought control strategies in differentiating those who are 
currently depressed from those who have previously been 
depressed and those who have never been depressed 
(Halvorsen et al., 2014).
As such, unhelpful metacognitions and ineffective 
thought control strategies are predicted to mediate HIV 
stigma with symptoms of depression and anxiety in MSM 
living with HIV. Specifically, it is hypothesised that (a) the 
relationship between greater enacted, internalised and antic-
ipated HIV stigma and more depressive symptoms will be 
mediated by greater Negative Metacognitive Beliefs, Need 
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to Control Thoughts and lack of Cognitive Confidence and 
more use of Worry as a thought control strategy and (b) the 
relationship between greater enacted, internalised and antic-
ipated HIV stigma and more anxiety symptoms will be 
mediated by greater Negative Metacognitive Beliefs and 
Need to Control Thoughts and more use of Worry and 
Punishment as thought control strategies.
Method
Participants
Participants were 106 gay, bisexual and other MSM living 
with HIV, aged 24 to 74 years (M = 44.6 years; standard 
deviation (SD) = 10.97 years). The majority of participants 
reported being born in Australia (73.6%) and currently liv-
ing in Australia (86.8%). Over half of the participants 
reported being in either full-time (39.6%) or part-time/ 
casual (18.9%) employment and 9.4 per cent reported being 
unemployed. The majority of participants reported having 
engaged in higher education (e.g. diploma or technical col-
lege = 26.4% or undergraduate degree = 27.7%). Nearly all 
of the participants identified their sexual orientation as gay 
(92.5%). Over half of the participants reported being single 
(57.5%) and 39.6 per cent reported being in a long-term 
relationship. The mean year of HIV diagnosis was 1999 
(SD = 9.2 years), with the majority of participants reporting 
that they were taking antiretroviral therapy (80.2%), had no 
current health problems associated with their HIV diagno-
sis and/or medication side-effects (65.1%) and had an 
undetectable viral load (73.6%). The mean year of starting 
antiretroviral therapy (ART) was 2003 (SD = 7.4 years). The 
demographic data are presented in Table 1.
Procedure
Participants were recruited by using posters, business cards, 
website advertisements, email banners and news stories 
within the MSM population. The study was advertised within 
the Sexual Health and HIV Service in Brisbane, medical cen-
tres, gay press social media sites (e.g. Facebook™, Twitter™ 
and online magazines), Queensland Universities, Ninemsn 
and HIV-positive websites in Queensland, Tasmania, South 
Australia, Western Australia and Victoria. Emails were 
sent and online advertisements were also posted on Poz 
Vibrations, a dating site for PLWH. Participants were asked 
to forward the survey link onto other MSM.
Measures
Demographics. Questions were asked regarding age, coun-
try of birth, country residing, postcode, highest level of 
education, main source of income, relationship status, year 
of HIV diagnosis and whether or not respondents experi-
enced health problems associated with their HIV diagnosis 
and/or HIV medication side-effects. Viral load detectability 
was scored on a 3-point Likert scale (‘Undetectable’, 
‘Detectable’, ‘Don’t know/unsure’). These questions were 
adapted from Australian studies (National Centre in HIV 
Social Research, 2009; Slavin et al., 2011).
HIV stigma. HIV stigma was assessed through Bunn et al.’s 
(2007) 32-item HIV Stigma Scale. The HIV Stigma Scale 
measures how stigmatised individuals feel in regard to liv-
ing with HIV. The HIV Stigma Scale included the follow-
ing factors: Enacted HIV Stigma (e.g. ‘I have lost friends 
by telling them that I have HIV’) comprised of six items 
measures the perceived overt experience of HIV stigma. 
Both Disclosure Concerns (e.g. ‘Telling someone I have 
HIV is risky’), which is made up of eight items, and Con-
cern with Public Attitudes about People with HIV/AIDS 
(abbreviated to ‘Public Attitudes’; e.g. ‘Most people are 
uncomfortable around someone with HIV’), which has six 
items, reflect the anticipation of HIV stigma in the future. 
Finally, Negative Self-Image (e.g. ‘I feel guilty because I 
have HIV’) has seven items and captures the internalisation 
of HIV stigma as being a valid part of one’s identity. Alpha 
levels for the HIV stigma factors in this study were .94, .90, 
.92 and .92, respectively.
Metacognitive beliefs. Participants completed the MCQ-30 
(Wells and Cartwright-Hatton, 2004). The MCQ-30 is com-
prised of five subscales rated on a 4-point Likert scale 
(1 = ‘Do not agree’, 2 = ‘Agree slightly’, 3 = ‘Agree moder-
ately’ and 4 = ‘Agree very much’). The MCQ-30 factors are 
as follows: Positive Metacognitive Beliefs about worry 
(e.g. ‘Worrying helps me cope’), Negative Metacognitive 
Beliefs about worry being uncontrollable and dangerous 
(e.g. ‘When I start worrying I cannot stop’), Cognitive Con-
fidence (e.g. ‘I have poor memory’), Need to Control 
Thoughts (e.g. ‘Not being able to control my thoughts is a 
sign of weakness’) and Cognitive Self-Consciousness (e.g. 
‘I pay close attention to the way my mind works’). Alpha 
levels for the MCQ-30 factors in this study were .88, .87, 
.91, .80 and .84, respectively.
Thought control strategies. Participants completed Wells and 
Davies (1994) 30-item TCQ, which measures five factors, 
each consisting of six items. The TCQ is rated on a 4-point 
Likert scale (1 = ‘Never’, 2 = ‘Sometimes’, 3 = ‘Often’ and 
4 = ‘Almost always’). The TCQ factors are as follows: Dis-
traction (‘I do something that I enjoy’), Social (‘I ask my 
friend if they have similar thoughts’), Worry (‘I worry 
about more minor thoughts instead’), Punishment (‘I pun-
ish myself for thinking the thought’) and Reappraisal (‘I try 
to interpret the thought’). Alpha levels for the TCQ factors 
in this study were .76, .79, .82, .67 and .72, respectively.
Depression. Depressive symptoms (e.g. ‘Do you have lit-
tle interest or pleasure in doing things’) experienced in the 
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last 2 weeks were assessed using the Patient Health Ques-
tionnaire (PHQ-9; Kroenke et al., 2001). Responses are 
rated on a 4-point Likert scale (0 = ‘Not at all’, 1 = ‘Sev-
eral days’, 2 = ‘More than half of the days’ and 3 = ‘Nearly 
every day’). This measure has previously been used with 
PLWH (Clarke et al., 2010; Mao et al., 2009; Monahan 
et al., 2009). The alpha level for the PHQ-9 in this study 
was .94.
Table 1. Descriptive characteristics of sample.
Characteristics n (%)
Country of birth
 Australia 78 (73.6)
 United States 14 (13.2)
 Other 14 (13.2)
Country currently residing
 Australia 92 (86.8)
 United States 13 (12.3)
 Other 1 (.9)
Highest level of education
 Primary/elementary school 1 (.9)
 Secondary/high school up to year 10 18 (17)
 Secondary/high school up to year 12 16 (15.1)
 Diploma or technical college/TAFE 28 (26.4)
 Undergraduate degree 29 (27.7)
Main employment status
 Full-time work 42 (39.6)
 Part-time or casual work 20 (18.9)
 Retiree 6 (5.7)
 Student 5 (4.7)
 Pension 23 (21.7)
 Unemployed 10 (9.4)
Relationship status
 Long-term relationship including de-facto or married 42 (39.6)
 Single including ‘widowed’ or divorced 61 (57.5)
 Short-term relationship 3 (2.8)
Sexual orientation
 Gay 98 (92.5)
 Bisexual 5 (4.7)
 Transgender 2 (1.9)
 Heterosexual 1 (.9)
Year diagnosed with HIV (M = 1999; SD = 9.2)
 1980–1987 14 (13.1)
 1988–1995 25 (23.6)
 1996–2004 21 (19.8)
 2005–2012 46 (43.4)
Currently taking ART, Yes 85 (80.2)
Year started ART
 1988–1993 12 (11.3)
 1994–1999 17 (16)
 2000–2005 15 (14.2)
 2006–2012 43 (40.57)
Has health problems associated with HIV or ART, Yes 37 (34.9)
Viral load
 Undetectable 78 (73.6)
 Detectable 20 (18.9)
 Don’t know/unsure 8 (7.5)
ART: antiretroviral therapy.
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Anxiety. Anxiety symptoms were measured through the 
Generalized Anxiety Disorder Questionnaire (GAD-7; 
Spitzer et al., 2006), which has seven items assessing how 
much an individual has been bothered by anxiety symp-
toms in the last 2 weeks (e.g. ‘Feeling nervous, anxious or 
on edge’). Responses are rated on a 4-point Likert scale 
(0 = ‘Not at all’, 1 = ‘Several days’, 2 = ‘More than half of 
the days’ and 3 = ‘Nearly every day’). This measure has pre-
viously been used with PLWH (Shacham et al., 2012). In 
this study, the alpha level for the GAD-7 was .95.
Analysis plan
Only the demographic variables that were significantly 
associated with the dependent variables (DVs; depression 
and anxiety) were used as covariates in the mediational 
models. Significant bivariate correlations between the inde-
pendent variables (IVs; HIV stigma types), mediators 
(metacognitive beliefs and thought control factors) and 
DVs (depression and anxiety) were included in hierarchical 
regressions. Given the possible large number of permuta-
tions that could be entered into the mediation models, only 
significant unique associations between the IVs and media-
tors and the DVs, after controlling for potential covariates, 
were included in mediational analyses.
The mediational models were assessed using Preacher 
and Hayes’ SPSS macros (Hayes and Preacher, 2012; 
Preacher and Hayes, 2008a), which allow for multiple 
covariates, mediators (INDIRECT macro) and predictors 
(MEDIATE macro). These macros were used to examine 
estimated path coefficients and bias-corrected bootstrap 
confidence intervals, for the total and specific effects 
between variables. Bootstrapping was chosen over the tra-
ditional Sobel test as it allows for multiple IVs and media-
tors, adjusts all paths for the potential influence of 
covariates, is reliable for smaller samples as it does not 
require assumptions of normality and has higher power 
while keeping reasonable control over Type 1 error 
(Preacher and Hayes, 2008b).
Results
Descriptive statistics for the DVs
Both the depressive and anxious symptom scores showed a 
good degree of variance with the mean score for depressive 
symptoms being 9.71 (SD = 8.38) and the mean score for 
anxiety symptoms being 8.25 (SD = 6.81). Using the cut-
offs for depressive symptomatology suggested by Kroenke, 
Spitzer and Williams (2001), 35 per cent of the sample fell 
within the minimal symptom range, 23.6 per cent were in 
the mild range, 9.4 per cent were in the moderate range, 
17.9 per cent were in the moderate-severe range and 14.2 per 
cent were in the severe depressive range. Using the cut-offs 
for anxious symptomatology suggested by Spitzer et al. 
(2006), 39.6 per cent of the sample feel within the minimal 
symptom range, 20.8 per cent were within the mild range, 
15.1 per cent were within the moderate range and 18.9 per 
cent were within the severe range.
Identifying potential covariates for mediation models
Of the demographics, only age and health problems related 
to HIV symptoms and/or HIV medication side-effects 
proved to have significant bivariate correlations with depres-
sion and anxiety (see Table 2), and so only these variables 
were included as covariates in the remaining analyses.
Testing the mediation model for depression
Variables with significant bivariate correlations were 
entered into a hierarchical regression analysis. Significant 
unique associations between the IVs (HIV stigma factors) 
and mediators (TCQ factors and MCQ-30 factors were 
entered separately) on the DV (depression), after control-
ling for the two covariates, were then used in the mediation 
model for depression. From this step, we found significant 
unique associations between (a) internalised (Negative 
Self-Image) and anticipated (Public Attitudes) HIV stigma 
and depression and (b) between two MCQ-30 factors 
(Negative Metacognitive Beliefs and Need to Control 
Thoughts) and two TCQ factors (Worry and Social) and 
depression. These variables were then entered into a boot-
strapping analysis controlling for age and health problems 
related to HIV symptoms and/or medication side-effects.
The relationship between internalised (Negative Self-
Image) HIV stigma and Social thought control was non-
significant (see the dotted line Path a in Figure 1). Zero was 
also contained within the biased-corrected bootstrap confi-
dence interval for this relationship, indicating that Social 
thought control was not a significant mediator for internal-
ised HIV stigma. Metacognitive beliefs based on the Need 
to Control Thoughts showed significant positive associa-
tions with internalised (Negative Self-Image) and antici-
pated (Public Attitudes) HIV stigma; however, it was not 
significantly associated with depression. Zero was also not 
contained within the biased-corrected bootstrap confidence 
intervals for these relationships, indicating that Need to 
Control Thoughts was not a significant mediator of depres-
sion in response to internalised (Negative Self-Image) or 
anticipated (Public Attitudes) HIV stigma.
Negative Metacognitive Beliefs and use of Worry as a 
thought control strategy significantly mediated the relation-
ship between internalised (Negative Self-Image) HIV 
stigma and depression (see bold pathways in Figure 1). 
More internalisation of HIV stigma as part of one’s identity 
was related to more depressive symptoms, indirectly 
through greater Negative Metacognitive Beliefs about 
thoughts being dangerous and uncontrollable and more use 
of Worry as a thought control strategy. This was indicated 
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by zero not being contained within biased-corrected boot-
strap confidence intervals for these mediators. The previ-
ously significant direct relationship between internalised 
(Negative Self-Image) HIV stigma and depression was also 
non-significant when the mediators were included (see 
internalised HIV stigma Path c and Path ć in Figure 1).
Negative Metacognitive Beliefs and Worry and Social 
thought control strategies significantly mediated the rela-
tionship between anticipated (Public Attitudes) HIV stigma 
and depression (see bold pathways in Figure 1). Thus, more 
anticipation of HIV stigma from the public was related to 
more depressive symptoms, both directly and indirectly, 
through greater Negative Metacognitive Beliefs, more use 
of Worry and less use of peers (Social thought control) to 
control distressing thoughts. This was indicted by zero not 
being contained within bias-corrected bootstrap confidence 
intervals for these mediators. The previously significant 
direct relationship between anticipated (Public Attitudes) 
HIV stigma and depression substantially dropped; how-
ever, it remained significant when the mediators were 
included (see anticipated HIV stigma Path c and Path ć in 
Figure 1).
The overall mediational model for depression ex-
plained 69 per cent of the variance, F(8, 97) = 26.95; 
p < .001. The mediators explained 24 per cent variance, 
FChg(5, 96) = 16.90, p < .001. Of the significant mediators, 
Negative Meta-cognitive Beliefs explained most of the 
unique variance (sr2 = 9.24), followed by Social (sr2 = 2.53) 
and then Worry (sr2 = 1.30) thought control strategies. 
There was an approximate 10 per cent overlap between 
the mediators in predicting depressive symptoms. It 
should be noted that a stronger direct relationship was 
found between anticipated (Public Attitudes) HIV stigma 
and depression (β = .42), than between internalised HIV 
stigma (Negative Self-Image) and depression (β = .22) 
prior to the mediators being included. Thus, more vari-
ance was needed to be explained by the mediators in order 
for the relationship between anticipated HIV stigma and 
depression to become non-significant when the mediators 
were included.
Testing the mediation model for anxiety
A hierarchical regressions analysis was performed using 
only significant bivariate correlations between the IVs 
(HIV Stigma factors) and mediators (MCQ-30 and TCQ 
factors assessed separately) on the DV (anxiety), while 
controlling for the two covariates. From this step we 
found significant unique associations between (a) inter-
nalised (Negative Self-Image) HIV stigma and anxiety 
and (b) between Negative Metacognitive Beliefs and the 
use of Worry and Punishment thought control strategies 
and anxiety. These variables were then entered into a 
bootstrapping analysis controlling for age and health 
problems related to HIV symptoms and/or medication 
side-effects.
Figure 1. Standardised coefficients for the depression mediational model.
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Greater use of Punishment as a thought control strategy 
did not significantly mediate the relationship between inter-
nalised (Negative Self-Image) HIV stigma and anxiety 
symptoms. This was indicated by zero not being contained 
within the biased-corrected bootstrap confidence interval 
for Punishment. However, Negative Metacognitive Beliefs 
significantly mediated the relationship between internal-
ised (Negative Self-Image) HIV Stigma and anxiety symp-
toms (see bold pathways in Figure 2). The use of Worry as 
a Thought Control strategy only narrowly missed criteria 
for statistical significance. Thus, greater internalisation of 
HIV stigma as being a valid part of one’s identity was indi-
rectly related to more anxiety symptoms, through more 
Negative Metacognitive Beliefs. This was indicated by 
zero not being contained within the biased-corrected 
bootstrap confidence intervals for these mediators. The 
previously significant relationship between internalised 
(Negative Self-Image) HIV stigma and anxiety symptoms 
was also non-significant when the mediators were included 
(see internalised HIV stigma Path c and Path ć in Figure 2). 
The overall mediational model for anxiety explained 
69 per cent of the variance: F(6, 99) = 37.42, p < .001. The 
mediators explained 36 per cent of the variance: FChg(3, 
99) = 38.62, p < .001. Of the significant mediators, Negative 
Metacognitive Beliefs explained most of the unique vari-
ance (sr2 = 23.62), followed by Worry (sr2 = 1.21). There 
was an approximate 10 per cent overlap between the media-
tors in predicting anxiety symptoms.
Discussion
This study examined a sample of MSM living with HIV. 
We hypothesised that the relationship between greater 
enacted, internalised and anticipated HIV stigma and more 
depressive symptoms would be mediated by greater 
Negative Metacognitive Beliefs, Need to Control Thoughts 
and Cognitive Confidence and more use of Worry as a 
thought control strategy. Additionally, the relationship 
between greater enacted, internalised and anticipated HIV 
stigma and more anxiety symptoms was predicted to be 
mediated by greater Negative Metacognitive Beliefs and 
Need to Control Thoughts and more use of Worry and 
Punishment as thought control strategies.
The results of the study found that of the stigma types, 
internalised HIV stigma was a unique predictor of both 
depression and anxiety symptoms, while anticipated HIV 
stigma from the public was also a unique predictor of 
depressive symptoms. These stigma types may be viewed 
as more intrapersonal experiences, highlighting the fact 
that MSM living with HIV may not necessarily need to be 
overtly discriminated against in order to experience psy-
chological distress (Deacon, 2006; Herek, 2002). PLWH 
generally know that HIV is a potentially stigmatised condi-
tion, with this knowledge motivating some PLWH to avoid 
discrimination, through social withdrawal and other behav-
iours which may limit life opportunities (Herek, 2002). 
This highlights the need to assess mental health outcomes 
in relation to specific aspects of HIV stigma, with the pro-
cess of internalising negative HIV perceptions particularly 
detrimental to mental health.
Negative Metacognitive Beliefs was the only metacog-
nitive beliefs to mediate the relationship between HIV 
stigma perceptions and depressive and anxious symptoms. 
This suggests that links between HIV stigma and depres-
sion and anxiety symptoms in MSM living with HIV may 
be connected to perceptions of one’s thoughts being dan-
gerous and uncontrollable. Negative Metacognitive Beliefs 
may increase the importance placed on HIV stigma thoughts 
Figure 2. Standardised coefficients for the anxiety mediational model.
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and in turn magnify the level of distress experienced. This 
is consistent with the previous research finding that 
Negative Metacognitive Beliefs has the strongest associa-
tion with depressive and anxiety symptoms (Spada et al., 
2008a, 2008b; Tajrishi et al., 2011; Yılmaz et al., 2011). It 
is also consistent with a recent finding that Negative 
Metacognitive Beliefs was the only metacognition (as 
measured by the MCQ-30) to differentiate currently 
depressed participants from previously depressed partici-
pants and those who have never been depressed (Halvorsen 
et al., 2014). These results are also consistent with Negative 
Metacognitive Beliefs being identified as the strongest 
metacognitive predictor of depression and anxiety symp-
toms in other chronic diseases such as Parkinson’s disease 
when controlling for disease factors (Allot et al., 2005). As 
such, Negative Metacognitive Beliefs appears to be a risk 
factor in understanding the psychological vulnerability in 
response to HIV stigma within some MSM living with HIV.
Contrary to prediction, the Need to Control Thoughts and 
lack of Cognitive Confidence were not found to be signifi-
cant mediators. These findings may be consistent with meta-
cognitive models of mental health disorders, which identify 
Negative Metacognitive Beliefs as being the most proxi-
mate to psychological distress (Wells, 2008). However, a 
lack of confidence in memory may be more of a byproduct 
of Positive and Negative Metacognitive Beliefs and 
increased severity of depressive symptoms (Papageorgiou 
and Wells, 2003). In this study, a community sample was 
used with a continuum of levels of depression and anxiety, 
as such metacognitive beliefs focused on a lack of confi-
dence in one’s memory may be more important in clinically 
depressed populations of MSM living with HIV. Similarly, 
contrary to a recent study by Halvorsen et al. (2014), we did 
not find any association between the use of Punishment as a 
thought control strategy and current symptoms of depres-
sion. It is possible that this may also reflect a difference in 
populations and requires further exploration.
The finding that more use of Worry as a thought control 
strategy mediated the relationship between HIV stigma and 
depression is consistent with previous research which has 
found that depressed patients focused significantly more on 
minor worries as a thought control strategy than on non-
clinical groups (Wells and Carter, 2009) and that that the 
Worry thought control strategy is associated with depres-
sive symptoms (Coles and Heimberg, 2005). Therefore, 
diverting one’s attention to minor worries in an attempt to 
control distressing thoughts may continue to orient indi-
viduals to the content of ruminations, and in turn prevent 
emotional distress from naturally subsiding (Wells and 
Carter, 2009). However, contrary to previous studies (Wells 
and Carter, 2009; Wells and Davies, 1994), Worry narrowly 
missed being significantly associated with anxious symp-
toms in this study. This may reflect a weaker association in 
this population than others and a need for a larger sample 
size in order to reach statistical significance.
The finding that anticipated HIV stigma from the public 
and depressive symptoms was mediated by less use of peers 
to control distressing thoughts (Social thought control) is 
contrary to our prediction which was based on previous 
inconsistent relationships between Social thought control 
and psychological distress (Barahmand, 2009; Wells and 
Davies, 1994). However, Social thought control has gener-
ally been identified as more of an adaptive strategy (Coles 
and Heimberg, 2005; Wells and Carter, 2009). This is con-
sistent with Wells and Carter’s (2009) finding that patients 
with GAD and patients with depression used Social thought 
control significantly less than non-patient controls. As 
such, some MSM living with HIV who anticipate HIV 
stigma from the public may be less likely to discuss these 
thoughts with peers in an attempt to suppress their distress 
and in turn may be more likely to experience depressive 
symptoms. Social thought control may offer a unique 
understanding of the link between the anticipation of HIV 
stigma from the public and depressive symptoms in some 
MSM living with HIV and is consistent with previous 
research findings that social support mediates the impact of 
HIV stigma on both depressive symptoms and quality of 
life in PLWH (Rao et al., 2012). Also, inconsistent with 
prediction, Punishment was not a significant mediator of 
anxiety and this may be a unique characteristic of this pop-
ulation that requires further research.
Limitations
The power to detect significant results may have been 
restricted due to the use of a smaller sample size (N = 106), 
and in-depth analyses with larger samples are recom-
mended within future studies. This study was cross- 
sectional and as such causation cannot be assumed and so 
the hypothesised causal pathways need to be confirmed in a 
larger longitudinal study. The use of future longitudinal 
studies is particularly important given that previous 
research finding experiences of internalised HIV stigma 
and depressive symptoms in PLWH may reduce over time 
(Steward et al., 2011). Metacognitive models assume that 
Positive Metacognitive Beliefs increase worry and/or 
rumination, which is then associated with Negative 
Metacognitive Beliefs and ineffective thought control strat-
egies (Wells, 2008). As such, Positive Metacognitive 
Beliefs may play an important role in earlier phases of the 
development of worry and/or rumination. In order to fur-
ther examine this, future longitudinal research using larger 
samples and structural equation modelling is needed. 
Another possible limitation to consider is that some of the 
association between the Negative Self-Image factor and the 
PHQ-9 may have been due to the similarities in the wording 
of some of the items from the HIV Stigma Scale (‘Having 
HIV/AIDS makes me feel that I am a bad person’, ‘I feel 
I’m not as good as others because I have HIV/AIDS’, ‘I feel 
guilty because I have HIV’) with one item from the PHQ-9 
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(’Feeling bad about yourself – or that you are a failure or 
have let yourself or your family down’). However, given 
that only one out of nine items of the PHQ-9 had such simi-
lar wording, we believe that this may have only had a small 
contribution to the overall associations. Finally, only MSM 
living with HIV were assessed, with participants predomi-
nately collected from HIV-positive websites, health centres 
and snowball sampling. Therefore, findings may not gener-
alise to all PLWH, or to MSM experiencing more severe 
HIV stigma concerns who potentially avoid all inadvertent 
opportunities of HIV disclosure.
Conclusion
HIV stigma involving internalised negative perceptions and 
anticipating stigma from others are associated with the 
experience of depressive symptoms in MSM who have HIV. 
This association is mediated by Negative Metacognitive 
Beliefs, as well as using Worry and Social thought control 
strategies. In contrast, anxious symptoms in MSM who have 
HIV are associated only with internalised HIV stigma and 
this association appears to be strongly mediated by negative 
metacognitions.
The results of this study provide preliminary evidence 
for the mediating role of metacognitions linking HIV stigma 
with the experience of depression of depressive and anxious 
symptoms in MSM. These findings provide insights into 
new directions for future research and interventions. For 
example, in addition to using HIV stigma campaigns to 
reduce HIV stigma in the wider community, interventions 
for MSM living with HIV and who are experiencing HIV 
stigma could also target negative metacognitions in order to 
reduce symptoms of depression and anxiety.
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